Axsome Therapeutics Announces Plans to Resubmit AXS-07 NDA Based on Successful FDA Type A Meeting
September 29, 2022 07:28 ET
|
Axsome Therapeutics, Inc.
NEW YORK, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...
Feel Therapeutics Launches its Ground-breaking Digital Precision Medicine Platform to Enable the Era of Precision Neuroscience and Psychiatry
September 22, 2022 07:41 ET
|
Feel Therapeutics
SAN FRANCISCO, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Feel Therapeutics Inc., a leading company developing digital biomarkers and therapeutics to bring objective measurement and data in mental health,...
Novartis plans to petition the U.S. Supreme Court to uphold validity of the Gilenya® (fingolimod) dosing regimen patent
September 21, 2022 01:00 ET
|
Novartis Pharma AG
Ad hoc announcement pursuant to Art. 53 LR Basel, 21 September, 2022 — Today, Novartis announced that the U.S. Court of Appeals for the Federal Circuit (CAFC) has denied its...
The Carrick Institute to Host 1-Day Concussion Bootcamp Workshop at 37th World Congress of Sports Medicine
September 20, 2022 14:00 ET
|
Carrick Institute
GUADALAJARA, Mexico, Sept. 20, 2022 (GLOBE NEWSWIRE) -- The Carrick Institute, world leader in clinical neuroscience education, proudly announced today that they will be delivering a 1-day...
XCPCNL Business Services Issues Letter From CEO
September 15, 2022 07:30 ET
|
XCPCNL Business Services Corporation
Charlotte, North Carolina, Sept. 15, 2022 (GLOBE NEWSWIRE) -- XCPCNL Business Services Corporation (OTC Pink: XCPL), a venture development business that leverages knowledge, skill, and experience in...
XCPCNL Business Services to Present at the Emerging Growth Conference on September 14, 2022
September 14, 2022 06:30 ET
|
XCPCNL Business Services Corporation
Charlotte, North Carolina, Sept. 14, 2022 (GLOBE NEWSWIRE) -- XCPCNL Business Services Corporation (OTC Pink: XCPL), a venture development business that leverages knowledge, skill, and experience in...
[Latest Report] Global Neuroscience Market Size Estimates and Forecasts [2022-2030] Worth $ 38.8 Billion by 2030 at a 4.7% CAGR: Custom Market Insights
September 05, 2022 14:11 ET
|
Custom Market Insights
London, United Kingdom, Sept. 05, 2022 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Neuroscience Market Size, Share, Growth Analysis Report By Type (Whole...
XCPCNL Business Services Successfully Completes Reverse Merger Acquisition Agreements with Centiment Capital Holdings
September 01, 2022 10:00 ET
|
XCPCNL Business Services Corporation
Charlotte, North Carolina, Sept. 01, 2022 (GLOBE NEWSWIRE) -- XCPCNL Business Services Corporation (OTC Pink: XCPL), a venture development business that leverages knowledge, skill, and experience in...
Identification of Symptom-Specific Brain Circuit Abnormalities in Obsessive-Compulsive Disorder
September 01, 2022 08:00 ET
|
Brain & Behavior Research Foundation
New York, Sept. 01, 2022 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Identification of Symptom-Specific Brain Circuit Abnormalities in...
Arvinas Reports Second Quarter 2022 Financial Results and Provides Corporate Update
August 04, 2022 07:00 ET
|
Arvinas Inc.
NEW HAVEN, Conn., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...